ISS in 24-country pharmaceuticals deal
Global pharmaceuticals company Novartis has significantly expanded its partnership with the ISS Group to cover all sites across 24 countries in Europe.
To continue reading this article
Enjoy unlimited access to i-FM and daily news headlines.
SIGNUP for a FREE Lite licence
or a Full licence with access to all the research and resources
If you already have a licence please login below
 |
